|
Tomlinson, S; Whitlow, M B; Nussenzweig, V (1994) A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9. J Immunol 152:1927-34
|
|
Tomlinson, S; Pontes de Carvalho, L C; Vandekerckhove, F et al. (1994) Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. J Immunol 153:3141-7
|
|
Whitlow, M; Iida, K; Marshall, P et al. (1993) Cells lacking glycan phosphatidylinositol-linked proteins have impaired ability to vesiculate. Blood 81:510-6
|
|
Iida, K; Whitlow, M B; Nussenzweig, V (1991) Membrane vesiculation protects erythrocytes from destruction by complement. J Immunol 147:2638-42
|
|
Iida, K; Ley, V (1991) Isolation and characterization of a 92-KD surface molecule of Trypanosoma cruzi amastigotes recognized by a monoclonal antibody that induces complement-mediated killing. Am J Trop Med Hyg 45:619-28
|
|
Whitlow, M B; Iida, K; Stefanova, I et al. (1990) H19, a surface membrane molecule involved in T-cell activation, inhibits channel formation by human complement. Cell Immunol 126:176-84
|
|
Iida, K; Whitlow, M B; Nussenzweig, V (1989) Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components. J Exp Med 169:881-91
|
|
Davitz, M A; Hom, J; Schenkman, S (1989) Purification of a glycosyl-phosphatidylinositol-specific phospholipase D from human plasma. J Biol Chem 264:13760-4
|
|
Davitz, M A; Gurnett, A M; Low, M G et al. (1987) Decay-accelerating factor (DAF) shares a common carbohydrate determinant with the variant surface glycoprotein (VSG) of the African Trypanosoma brucei. J Immunol 138:520-3
|
|
Caras, I W; Davitz, M A; Rhee, L et al. (1987) Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325:545-9
|
Showing the most recent 10 out of 15 publications
